- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00721604
Fluid Responsiveness Prediction at the Bedside
Prediction of Volume Expansion Effectiveness in Hypotensive Critically Ill Patients.
Study Overview
Detailed Description
Severe hypotension is a common life-threatening conditions in critically ill patients. Discriminating between the need for volume expansion or inotropic/vasoactive support is a main clinical goal. Pulse pressure variation are an accurate index of fluid responsiveness, but it needs controlled mechanical ventilation with a tidal volume of at least 8 ml/kg and absence of arrhythmias. This could limit its clinical applicability. Moreover pulse pressure variation accurately predicted cardiac output increment. However the cardiac output increase is not a clinically relevant target in absence of low cardiac output.
The objectives of the present protocol are: 1) to calculate the accuracy of cardiovascular and renal variables to predict either arterial pressure increase or clinically relevant improvement after fluid administration and 2) to verify how often dynamic indices could be applied in clinical practice.
Arterial pressure increase is defined by mean arterial pressure above 65 mmHg or an increment greater than 20 % respect to basal value. Clinically relevant improvement is defined by restoring adequate values of arterial pressure or cardiac index or diuresis or central venous saturation if they are inadequate before fluid administration. These adequate values are 65 mmHg for mean arterial pressure, 2.5 l.min-1.m-2 for cardiac index, 0.5 ml.kg-1.h-1 for the diuresis, 70 % for central venous saturation.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Brescia, Italy, 25124
- Intensive Care Unit, Fondazione Poliambulanza Istituto Ospedaliero
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- mean arterial pressure lower than 65 mmHg
Exclusion Criteria:
- fluid overload
- mean arterial pressure lower than 45 mmHg and mandatory immediate treatment
- active bleeding
- hemoglobin lower than 8 g.dl-1
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
1
patients with mean arterial pressure lower than 65 mmHg
|
two consecutive infusions of 6% hydroxyethyl starch at the dosage 7 ml/kg over 30 minutes (total 14 ml/kg in 60 minutes)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
area under ROC curve of pulse pressure variation before volume expansion and their positive and negative predictive values; responders are patients increasing mean arterial pressure
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
area under ROC curve of pulse plethysmographic variation before volume expansion and their positive and negative predictive values; responders are patients increasing mean arterial pressure
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
area under ROC curve of pulse pressure variation before volume expansion, positive and negative predictive values; responders are patients showing any clinical improvement
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
area under ROC curve of pulse plethysmographic variation before volume expansion, positive and negative predictive values; responders are patients showing any clinical improvement
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
area under ROC curve of central venous pressure before volume expansion and their positive and negative predictive values; responders are patients increasing mean arterial pressure
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
area under ROC curve of central venous pressure before volume expansion, positive and negative predictive values; responders are patients showing any clinical improvement
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
area under ROC curve of central venous saturation before volume expansion, positive and negative predictive values; responders are patients showing any clinical improvement
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
area under ROC curve of central-arterial PCO2 pressure difference before volume expansion, positive and negative predictive values; responders are patients showing any clinical improvement
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
area under ROC curve of arterial lactate before volume expansion, positive and negative predictive values; responders are patients showing any clinical improvement
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
area under ROC curve of fractional excretion of sodium before volume expansion, positive and negative predictive values; responders are patients showing any clinical improvement
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
area under ROC curve of sodium/potassium urinary ratio before volume expansion, positive and negative predictive values; responders are patients showing any clinical improvement
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
comparison between the number of patients with criteria for pulse pressure variation calculation and the number of patients with other predictive variables
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
estimation of variables independently associated to arterial pressure increase
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
|
estimation of variables independently associated to clinically relevant improvement
Time Frame: one hour after the end of fluid administration
|
one hour after the end of fluid administration
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FP-TIP-03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.